Exhibitors BIOMARKER AGORA 2017
Below please find the list of exhibitors at the Biomarker AGORA 2017, which will be updated during the next month.
Alzheimerforeningen er en medlemsorganisation, der har til formål at sikre bedre vilkår for mennesker med demens og deres pårørende. Vi rådgiver, informerer og støtter forskning i demenssygdomme. Vi er en forening for alle med interesse for demens, og vores medlemskreds omfatter både mennesker med demens, deres pårørende og fagfolk på demensområdet. Medlemmerne har den fælles holdning, at alle, der er berørt af demens, skal have mulighed for et godt og indholdsrigt liv
Is your science beautiful? Now the University of Copenhagen faculty of SCIENCE invites you to combine art and science and to share your beautiful science visualizations.
Did your data points form a painting worthy of a Jackson Pollock?
Do your expedition images look like National Geographic's?
Does your crystallography resemble the cubist works of George Braque?
Is your instrument attractive, your laboratory animal charming or your sample gorgeous?
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions by applying scientific excellence and outstanding service and employing a team of some of the foremost scientific professionals in the industry. These Drug Discovery and Development professionals offer proven experience in key therapeutic areas. They share a legacy of success, having advanced a large number of molecules efficiently, expeditiously and economically, from early discovery through clinical development with low attrition rates.
Bioneer A/S is an innovative research-based company providing services within biomedicine and biotechnology.
The commercial mission is to increase the competitiveness of global customers by facilitating their early, explorative development of new therapeutics. Bioneer offers access to essential tools, technology and unique biological resources within cell and molecular biology, and further aims to create new product opportunities at the interface between biology and other sciences.
Your partner in the life sciences and clinical diagnostics for more than 60 years.
BioXpedia provides analytical biomarker services to pharmaceutical and biotech industry, research groups on hospitals and universities and other larger research institutions. The main focus is on the identification of new biomarkers for patient stratification, treatment response, and discovery of potential drug targets.
Accellerate the internationalisation of your life sciences innovation.
Biopeople is partner in the Boost4Health program that provides practical and financial support to small and medium-sized enterprises who wish to explore their international growth potential. If you wish to increase your international network, find expertise abroad, validate your products in another market: join Boost4Health!
BOREAN Innovation is one of four innovation incubators in Denmark. The incubators are approved as operators by The Danish Agency for Science, Technology and Innovation under the Ministry of Higher Education and Science. The incubators provide professional counselling, pre-seed and seed capital for entrepreneurs and new innovative enterprises.
Breathe projekt: Lungemedicinsk Forskningsenhed på Bispebjerg Hospital står i spidsen for et nyt, stort forskningsprojekt (BREATHE), som skal give lægerne ny viden om astma og KOL. Ifølge overlæge og professor Vibeke Backer, der både har udarbejdet idéen, protokol og ansøgningen til projektet, er det unikke ved BREATHE, at der er tale om forskning for og med den almindelige patient med KOL eller astma. Det er nemlig et uselekteret studie, som inkluderer alle de KOL og astma patienter, der henvises til ambulatoriet.
Brain+ creates apps that are digital cognitive remediation centers, which engage patients in intense and long term motivating cognitive exercise regimes, with therapist support or as self-care
The British Embassy in Copenhagen maintains and develops relations between the UK and Denmark.
Services if you're visiting, studying, working or living in Denmark. Includes information about trading with and doing business in the UK and Denmark.
Cellevate is an innovative biotech company that develops the next generation of cell culture systems. We create highly porous and consistent networks of nanofibers through a patented manufacturing process. Cells in these networks are allowed to proliferate and interact with other cells in three dimensions (3D), in contrast to the monolayer cultures seen on conventional two dimensional (2D) surfaces. Our goal is to provide life science researchers with more realistic in-vitro models, for more relevant data and successful research.
CiToxLAB was created through the merger of CiT and LAB Research, provides a comprehensive range of preclinical and specialty services from our facilities in France, Canada, Denmark and Hungary.
The CopenhAgen Center for HEalth Technology [cachet] is a strategic research partnership between the Capital Region of Denmark, the City of Copenhagen, the University of Copenhagen, and the Technical University of Denmark. Through evidence-based technological research, we want to create the foundation for new personalized health technologies and products for the benefit of citizens and the society in general.
Over the years the Danish society has invested considerable sums in building a range of national registers containing information about all residents in Denmark. In the same way the Danish health system has routinely collected biological material from a large number of individuals.The main purpose of the Danish National Biobank is to give scientists from Denmark and abroad overview of and access to more than 22 million biological samples in both existing and future collections.
The Danish National Biobank initiative has 3 pillars:
- The Danish Biobank Register with detailed information about the samples available in the Danish health system and in the large, participating research biobanks.
- The physical National Biobank that stores and retrieves samples for Danish scientists.
- The Coordinating Centre where a strong research environment offers know-how to scientists and external biobanks
IT’S ALL ABOUT THE BRAIN!
The DRCMR is one of the leading research centres in Europe within the field of biomedical MRI. A highly profiled international research team translates the latest advances in MRI to examine the brain's function, metabolism and structure.
University of Copenhagen is a core partner in two Knowledge Innovation Communities (KICs) related to the areas of Health and Climate. A KIC is, in essence, innovation in action. It covers the entire value chain from education to R&D, demonstration, start-up incubation, marketing and sales. It is a living entity – a dynamic partnership, ready to adapt to the changing realities of its field and the emerging needs and challenges of Europe.
ELPRO is a leading Swiss manufacturer of innovative monitoring solutions and data loggers for documenting environmental conditions in production facilities, warehouses and the cold chain. We partner with our clients to develop solutions that integrate our high-quality measurement components into their business processes.
Epilepsihospitalet er Danmarks eneste højt specialiserede hospital for patienter med epilepsi. Mange års fokus på epilepsi har gjort os til eksperter, også når det gælder de sygdomme, som ofte følger med epilepsi og hjerneskade. Dermed har vi opnået specialviden og stor erfaring med at behandle mennesker inden for de områder. På hospitalet har vi også ekspertise på de felter, der grænser op til epilepsi eller er en deldiagnose til epilepsi. Derfor kan vi i dag også løse opgaver inden for erhvervet hjerneskade, psykiatriske problemstillinger, udviklingshæmning og søvnlidelser.
Eurofins Genomics, a division of the Eurofins Scientific Group, is a leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services.
Situated in the heart of Europe, yet forging connections all over the world, ETH Zurich is pioneering solutions to the global challenges of today and tomorrow. It has more than 19,000 students from over 120 different countries.
GATC Biotech has been advancing the DNA sequencing field since 1990. As Europe’s first sequencing service provider, the company holds unmatched experience in all sequencing-related matters.
HØIBERG is a full service patent company providing services within the fields of Intellectual Property Rights (IPR), including Patents, Designs, Innovation Management, Technology Transfer and Business Development.We provide expert IPR knowledge in the fields ranging from biotech, medtech, nanotech, chemistry and cleantech to software, electronics and mechanics.We assist you at every stage of development – from idea to realisation.
Innovation Department, Pernille Woller: We help bring good healthcare ideas to life. Idéklinikken is the Innovation department of the North Denmark Region and is located at Aalborg University Hospital. The main focus is to collect, develop, test and eventually bring to market good ideas for new products and inventions within the special and healthcare sector. The ideas are primarily initiated by, and based on needs and requirements from, health care professionals but also private actors e.g. patients and relatives can bring their idea into play. Our team covers a wide range of competencies - from industrial design, idea and project development to commercial law, and commercialization and amongst the services offered are idea evaluation, idea development, prototyping, proof of concept/business, test and production, collaborations about IPR and CE-mark etc. Our portfolio consists of various products and inventions and nothing is left to be untouched as long as it can make the work better, faster and/or safer, and bring value to the benefit of the professionals, the patients and/or the North Denmark Region.
EV Array: high-throughput Multiplexed Phenotyping of Extracellular Vesicles (EVs):Simona Padurariu,Msc, Business Developer, Clinical Immunology Department: EV Array is an unique biomarker platform that can exploit the intercellular trafficking in various biofluids to provide a non-invasive method for diagnostics and prognostics. The EV Array is based on the technology of protein microarray and allows for the detection and phenotyping of EVs from unpurified starting material in a high-throughput manner. The technology was developed to perform multiplexed phenotyping of EVs in an open platform. The EV Array has been optimized for plasma, but can analyze urine, saliva, ascites, bone marrow, and cerebrospinal-, synovial- and bronchoalveolar fluids as well.The apparent role of EVs in a vast number of biological processes, forms the basis of extending EV analysis beyond basic research and into clinical and therapeutic context. The applications of this type of analysis include the areas of diagnostics and prognostics, as well as drug therapy, regenerative medicine, and vaccines. The analysis of EVs could be incorporated as a screening tool and applied to confirm a diagnosis. Furthermore, the EV Array analysis has the potential to become an element in treatment surveillance and companion diagnostics. The EV Array technology is currently optimized for a small-to-medium laboratory research scale. Several studies have demonstrated the EV Array efficiency in detecting cancers, lung-related diseases (pneumonia, COPD), venous thrombosis, multiple sclerosis and malaria.
Predictive Biomarkers for Early Identification of Hypoxemia and Acute Lung Injury, Simona Padurariu,Msc, Business Developer, Ideklinikken: We have identified a specific combination of biomarkers that determines the risk of developing acute lung injury (ALI) and acute respiratory distress syndorme (ARDS) 2-3 days before the symptoms appear, and already during a surgical intervention. We have also developped a tailored software application for a fast assesment of the risk of disease progression directly from NMR spectra. The method has been tested in a second clinical trial including 900 cases. Our method has great potential as an early diagnostic tool, as well as for monitoring and personalized medicine after cardiac surgery.
Søren Kaalund Center for Arthrosis.
Intomics helps clients from the pharmaceutical industry with a variety of projects involving bioinformatics and systems biology. Intomics’ services are within Pharmaceutical Research & Development and Intomics has in-depth knowledge in applying biomedical big data throughout the drug development value chain.
Leymus Genomics offers industry leading products and services for genomic analyses ( NGS ) for the Nordic countries and Germany. We are based in Copenhagen and founded and operated by employees coming from the NGS and Diagnostic industry.
Lupus Friends and Family was built on a patient-to-patient platform providing support and resources needed to motivate and inspire patients to keep fighting. We spread love and lupus awareness and facilitate patient events and free online and face-to-face support group meetings. We are a 501(c)(3) not-for-profit organisation accepting tax deductible donations in order to make a difference in lupus patients’ lives.
Mandly is a search and recruitment company specializing in the fields of Life Science, Hospital & Healthcare, IT and FMCG . We know how to find top candidates that best suit your company in the Nordic area. We provide both search, recruitment and second opinion. We maintain extensive contacts and a comprehensive database of sales and marketing personnel, leaders, specialists and professionals. We are able to serve our client companies with adjunct support in the development and staffing processes.
Medical Prognosis Institute is a precision medicine company with a remarkable mission to help find personalized cures for cancer.
Medicologic is a leading Danish design and engineering company specializing in innovation, product development, usability, design for manufacturing and quality assurance within the medical device sector.
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers. We create value for our members by co-hosting, launching and driving meetings, working groups, seminars, conferences and projects, that strengthen the collaboration, networking and knowledge-sharing in the regions life science community, create critical mass and help realizing the full potential of Medicon Valley.
Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.
Meso Scale Diagnostics is a rapidly growing company specializing in the field of bio-measurements. Our work environment provides the security of an established company combined with the benefits of an innovative culture where everyone has the opportunity to make a difference in the field of biomedical research. Our collaborative approach identifies challenges as we work together to create solutions.
Monsenso helps healthcare providers, researchers, and individuals overcome the burden of mental illness and empower individuals by helping them become more involved in their treatment.
MS-Omics is an independent company founded in 2014 and located at University of Copenhagen in close collaboration with the Research Center for Advanced Analytical Chemistry (RAACE), and the chemometrics group.
Administering an ineffective oncology product to a cancer patient may be life threatening. An oncology product may cure one patient but maybe worthless or even harm another patient. Many oncology products only benefit a very small fraction of patients and there is no way to identify who will benefit. This forces oncologists to treat many patients in the blind, and if the fraction of benefiters is too low the product will not be used even if such a product may be the best product for certain patients.
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. NanoString’s technology offers a polymerase-free nucleic acid quantification platform and hybridization chemistry that is 100% digital.
Multiplex 20–800 targets in a single tube
Our 3D Biology Technology offers the ability to measure DNA, RNA, and protein simultaneously, and is crucial to developing a comprehensive understanding of biology in the genomics era. NanoString Technologies has developed the nCounter® Analysis System for use in high-resolution multi-parameter analysis of biomolecules—the ability to measure any combination of DNA, RNA, and protein using a single detector from a sample of limited volume and concentration. Read more
Helle Naver, Ph.D. Principal Scientist
Formulation stability is optimized by designing the formulation reaching the highest oligomeric state which does not precipitate or is kept in solution. If the lead does not oligomerise the formulation can be optimized by addition of excipients protecting the most reactive sites on the lead both chemical reactive and physical reactive. Eventually the reactive sites may be stabilized by mutagenesis/synthesis. Stability analysis measures any potential changes which would affect lead mode of action. Information about changes which do not affect the mode of action could in principle be considered irrelevant and as too much information. Therefore is the starting point a method or method collection which describes every degradation product and their influence on receptor binding and mode of action. If possible will the methods of choice only describe relevant degradation products and impurities. Degradation products and impurities resembling the main compound most will most likely be those which are hardest to measure but are potentially also those which resemble most in mode of action. Suggestions for lead development, delivery, formulation, stability and analysis.
Now in business for nearly 20 years, Nordic BioSite is recognized as a leader in supply of products for research and diagnostic, Immunology and Molecular Biology, to Pharmaceutical, Biotech, Diagnostic and to academic researchers.
PentaBase ApS is a privately held company founded in 2006, having roots back to the invention Intercalating Nucleic Acid, INA, made by the founder of PentaBase, Ulf B. Christensen and published in 2002 [Christensen UB and Pedersen EB, Nucl. Acid. Res., 2002, 30, 4918-4925]. Today PentaBase has refined INA, and made it usable on standard instruments used in most molecular biology facilities around the world. We call the proprietary monomers in our updated INA for “pentabases”.
The Psoriasis organisation works to improve the lives of 165.000 Danes with psoriasis in Denmark.
A bio bank is a collection of biological material (eg blood and tissue) that is stored according to applicable law. In Denmark we have the best opportunities to increase health through the use of health data in science and treatment. We can target treatment and prevent many illnesses for the future generations using health data. This is due to our unique registers, data and bio banks combined with the organization of our health care system. The regions wish to support this work by making one point of entry to the bio banks in Denmark.
Louise Dalgaard, Roskilde University
SAS is the leader in analytics. Through innovative analytics, business intelligence and data management software and services, SAS helps customers at more than 83,000 sites make better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.
Scifeon is all about providing scientists with better informatics on a day-to-day basis. It is the next generation of research data management software specifically developed for scientist by scientists. Scifeon is quite simply developed to fit the needs and requirements of the end-users by having four essential elements imbedded in its software DNA.
We present some of the insights from the project ”Biomarkers as an emergent area of growth” from an anthropological study, performed by Dorthe Brogård Kristensen and Birgitte Bruun from Brandbase, SDU. Patients and patients’ organizations have a unique experience of living with a disease, and can therefore contribute with important insights relevant for the research into biomarkers. The poster identifies some of the potentials and challenges in research collaboration between patients, researcher and pharmaceutical companies.
Camilla Thygesen, Health SDU
Patienten som partner i dansk sundhedsforskning – Et nationalt vidensdelingsprojekt om brugerinddragelse i forskning. Marianne Sandvei (email@example.com)& Mogens Hørder (firstname.lastname@example.org ) Forskningsenheden for Brugerperspektiver, Institut for Sundhedstjenesteforskning, Syddansk Universitet: Over de seneste 15 år har patienter i stadigt højere grad medvirket aktivt ved planlægning, gennemførelse og implementering af forskning. Udviklingen har især taget fart i England og USA, og en tilsvarende udvikling er på vej i Danmark. Inddragelse af patienter i forskning kan påvirke forskningens sigte og dermed forskningens resultater og samfundsrelevans. I det nationale videndelingsprojekt ”Patienten som partner i dansk sundhedsforskning” er der foretaget en afdækning af status for initiativer omkring brugerinddragelse i forskning i danske forskningsudførende og forskningsfinansierende institutioner inden for sundhedsvidenskab. Afdækningen er foretaget på såvel forskningsstrategisk niveau som på projektniveau og viser overordnet set en varierende, men tiltagende udvikling på området. Behovet for læring og vidensdeling om rammer vilkår, muligheder og barrierer er stor for såvel patientrepræsentanter, sundhedsprofessionelle som ledere.
Synapse - Life Science Connect is a student-driven, non-profit organization in the Copenhagen Area that creates events, workshops, and networking opportunities for students and young professionals with an interest in pursuing careers in the life science environment. It is a thriving organisation consisting of a group of dedicated volunteers based at the University of Copenhagen (UCPH) and the Technical University of Denmark (DTU) that strive to bridge the gap between the university bioscience community and the life science industries.
Takara Bio is part of Takara Holding Company Inc, and represents the biomedical business interests of its parent company. Takara Bio is committed to improving the human condition through biotechnology through three primary areas of focus; developing research tools for the life sciences, gene therapy, and nutraceuticals. Takara has been focusing on biomedical research since it launched the Bio group in 1967.
Asli Silahtaroglu: Department of Cellular and Molecular Medicine
The Biomedical Department at the Faculty of Health and Medical Sciences delivers the highest quality basic science with a clear clinical perspective. We strive to contribute with new knowledge for the benefit of the treatment of patients within a broad range of research areas including diabetes, coronary heart diseases, obesity and cancer. Our research profile is thus cross-disciplinary and translational and build on a tradition of collaboration with the clinic and the industry.
Biotech Research & Innovation Centre (BRIC) was established in 2003 by the Danish Ministry of Science, Technology and Innovation to form an elite centre in biomedical research.The aims are:
- perform interdisciplinary, cutting-edge research
- establish a strong research education programme
- attract funding and new research projects
- ensure that research results are used for the development of commercial products
- promote exchange of ideas within the Danish biotech research community
Center for Healthy Aging: Aging begins early in life, and human behavior and lifestyle affects health and life course. Center for Healthy Aging is a research center that studies how more people can have a healthy life and healthy aging. The approach to research is interdisciplinary and the center studies aging and aging processes from cell to society.The Center for Healthy Aging is a network of research units, most of which are currently located at the University of Copenhagen and the Dean of the Faculty for Health and Medical Sciences Ulla Wewer has overall responsibility for the Center. The other research units are based at the Faculties of Humanities and Social Sciences as well as a number of hospitals.
Lisbeth E Knudsen
The Department of Biology forms a part of the Faculty of Science at the University of Copenhagen. The department carries out research and offer courses at bachelor, masters and PhD level.
The Department of Biology is the largest institute at the Faculty of Science. At present the staff includes more than 400 employees - almost distributed equally between researchers and technical/administrative positions. The study program attracts more than 1800 students.
Nano-Science Center is a cross-faculty initiative between the Faculty of Science and the Faculty of Health and Medical Sciences. In September 2001 the Center was inaugurated as a joint venture between the Niels Bohr Institute and the Department of Chemistry at the University of Copenhagen. Today, the research member groups also come from several departments at the Faculty of Health and Medical Sciences. The Center was the first in Denmark to introduce a full bachelor and master's programme in Nanoscience. Today more than 250 students are studing nanoscience at Nano-Science Center. Many candidates choose to do a PhD, others do career in industry. In total, more than 150 scientists, postdocs and PhD students are associated with the Center.
Vanessa Hall, Associate Professor, Group Leader of the Stem Cell Brain group, University of Copenhagen. The Stem Cell Brain group will present the current research activities being undertaken in the group, including modelling neurodegenerative diseases using induced pluripotent stem cells from human patients and using the developing pig brain as a model of human brain development and applying modern sequencing methods on the developing pig brain to determine cell types and molecular expression of interesting cell types that are affected in Alzheimer's disease.
Sofie Otzen Bagger
Wildcard Pharmaceutical Consulting is offering machine learning, advanced data analysis and IT solutions to pharmaceutical and drug discovery companies. By combining domain insight with IT knowledge and specialized software, we can deliver results and the customized tools and analyses that your business needs to succeed.
YSDS is a Swedish company with HQ in Stockholm and offices worldwide. YSDS Öresund covers Denmark and south of Sweden. When it comes to Pharma & Life Science, YSDS is your committed and reliable Full-Service Partner. We handle all types of TCS (temperature controlled shipments). You will get superior service no matter what or where in the World you are shipping. Since we are an independent company, we will always use the best shipping method and network for your specific shipment.
Personalised Rheumatic Medicine with OMICs Technologies
Personalised or individualized rheumatic medicine is in its infancy and we expect that overall treatment costs will decrease as this field develops. Our approach to personalized medicine involves the development of immune response monitoring assays. These assays are intended to measure the patient immune system response to a given anti-inflammatory drug. So far our assays enable to investigate cell specific responses to treatment, which provides insight into metabolic and signaling changes.
The vision of Department of Health Science and Technology, HST, is to improve health throughout society by development of new devices, methods and therapies, and by prevention of illness. Specifically, the North Denmark Region is a field of interest, the aim being to reduce the shortage of doctors and collaborate with industry.
Personalised Monitoring of AC treatment (former Coa Care): Søren Lundbye Christensen, Senior Biostatistician, Peter Brønnum Nielsen, Post Doc, Cardiology Research Group: We have created a product for personalized management of the anti coagulation treatment, aiming to reduce bleeding and stroke incidents, and to limit the re-admittance to hospitals due to complications.The product consists of an advanced decision support algorithm, which ensures that every patient takes the optimal dose of medication for anti coagulation treatment every day.Two studies has demonstrated the efficacy of the algorithm; a retrospective study on 556 patients demonstrated that it can predict the effect of anti coagulation medication, and a RCT study on 198 patients demonstrated that it can determine the optimal dose of medication for anti coagulation treatment. The concept for the medical app and backend has been developed, and is currently being validated in a user group of anti coagulation patients.In Europe, 24 million people lives with atrial fibrillation or heart valve diseases that requires anti coagulation treatment. The treatment with vitamin K antagonists is however difficult to manage as the medicine requires highly individual dosing, is affected by food intake, and interacts with most other medicines. Therefore, the treatment needs to be frequently monitored. The products will be offered through subscriptions, with a market potential of approx. DKK 13 billion.
CD 36, new risk marker for cardiovascular disease and diabetes, Aase Handberg, Professor, Clinical Biochemistry Department: We have discovered a form of CD36 in blood that is not bound to cells and thus more easily measured. We have developed and validated an ELISA assay and documented that CD36 in plasma is increased in type 2 diabetes and pre-diabetic conditions related to cardiovascular risk. It will enable deployment of targeted individualized intensive preventive treatments in which symptomatic cardiovascular disease can be reduced. By identifying patients at high risk for atherosclerosis and cardiovascular disease, this new test will allow individualized preventive treatment. The test is based on measuring CD36 in a blood sample, assessing the accumulation of cholesterol in the blood vessel wall, the atherosclerosis process as well as the fatty acid uptake in insulin sensitive tissues related to the development of insulin resistance in obesity. Whilst there are a number of indicative tests available to date (lipid profile, C-reactive protein, cholesterol etc.) there continue to be concerns about their ability to discriminate those patients at serious risk of developing the clinically relevant disease. A validated predictive/discriminating biomarker is a potential clinically valuable application as a diagnostic tool for identifying at risk patients and for disease monitoring supporting both prophylactic and therapeutic interventions.
Malene Møller Jørgensen